Li Zhang

CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study

Shimin Hu, Zijun Y. Xu‐Monette, Aarthi Balasubramanyam et al. · Blood · 2013 · 246 citations · Full text

Medicine, Hematology, Oncology +14

Genetic basis of PD-L1 overexpression in diffuse large B-cell lymphomas

Longyun Chen, Mattias Berglund, Weicheng Ren et al. · Blood · 2016 · 201 citations

Medicine, Genetics, Molecular Genetics +16

Prognostic impact of concurrent <i>MYC</i> and <i>BCL6</i> rearrangements and expression in <i>de novo</i> diffuse large B-cell lymphoma

Qing Ye, Zijun Y. Xu‐Monette, Alexandar Tzankov et al. · Oncotarget · 2015 · 115 citations · Full text

Medicine, Cancer Biology, Oncology +15

Dysregulated CXCR4 expression promotes lymphoma cell survival and independently predicts disease progression in germinal center B-cell-like diffuse large B-cell lymphoma

Jiayu Chen, Zijun Y. Xu‐Monette, Lijuan Deng et al. · Oncotarget · 2015 · 80 citations · Full text

Medicine, Immunology, Oncology +15

Clinical and Biologic Significance of <i>MYC</i> Genetic Mutations in <i>De Novo</i> Diffuse Large B-cell Lymphoma

Zijun Y. Xu‐Monette, Qipan Deng, Ganiraju C. Manyam et al. · Clinical Cancer Research · 2016 · 66 citations · Full text

Medicine, Molecular Genetics, Oncology +17